ESC 365 - How should ATTR cardiac amyloidosis cardiomyopathy be treated?

ESC Professional Premium Access

How should ATTR cardiac amyloidosis cardiomyopathy be treated?

Session: Management of cardiac transthyretin amyloidosis with or without aortic stenosis

Topic: Treatment

Speaker: Professor T. Damy (Creteil, FR)

Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

31 presentations

1 follower

3 more presentations in this session

What is ATTR cardiac amyloidosis and how is it diagnosed?

Speaker: Doctor M. Corneli (Buenos Aires, AR)

How common is ATTR cardiac amyloidosis in aortic stenosis and how does it impact on management?

Speaker: Doctor T. Treibel (London, GB)

Management of cardiac transthyretin amyloidosis with or without aortic stenosis – discussion.

Access the full session

Management of cardiac transthyretin amyloidosis with or without aortic stenosis

Speakers: Professor T. Damy, Doctor M. Corneli, Doctor T. Treibel

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by